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Conclusion. Our data suggest that JNK phosphorylation isVitamin E-modified filters modulate Jun N-terminal kinase
strikingly increased in PBMCs obtained from CA-treated pa-activation in peripheral blood mononuclear cells.
tients and may represent a key cellular event in PBMC activa-Background. The generation during hemodialysis of acti-
tion during dialysis with bioincompatible membranes. The acti-vated complement fragments and reactive oxygen species, in-
vation of this signaling enzyme, mediated by active complementcluding nitric oxide (NO), may affect peripheral blood mono-
fragments and PBMC-dialyzer interaction, can be significantlynuclear cell (PBMC) function. Currently, little is known about
reduced by the use of vitamin E-coated membrane.signal transduction pathways involved in PBMC activation. Jun
N-terminal kinase (JNK) is a novel mitogen-activated protein
(MAP) kinase phosphorylated and activated in response to
oxidative stress and directly involved in cell activation.
During hemodialysis blood contact with a complement-Methods. The present study evaluated the activation of JNK
activating membrane may promote a variety of complexin PBMCs isolated from eight uremic patients undergoing,
in a randomized manner, three month-subsequent periods of and interrelated events, leading to an acute inflammatory
hemodialysis with a low-flux cellulose acetate (CA) and a vita- response. In particular, activation of mononuclear cells
min E-modified cellulose membrane (CL-E). After each period induces the release of an array of pro-inflammatory com-
of treatment, PBMCs were harvested before (T0), during (T15)
pounds into the extracellular environment [1]. It is welland after three hours (T180) of dialysis. At the indicated time
known that in the long term these pro-inflammatory mol-points, plasma C5b-9 generation by ELISA and inducible NO
synthase (iNOS) gene expression by in situ hybridization were ecules may mediate, at least in part, numerous clinical
evaluated also. The activation of JNK was studied by Western complications observed in hemodialyzed patients [2].
blotting using a specific monoclonal anti-phospho-JNK anti- Although the clinical consequences of the immune cell
body, which recognizes the activated form of JNK.
activation have been clarified, the intracellular mecha-Results. At T0, a significant increase in plasma C5b-9 levels
nisms turning on peripheral blood mononuclear cellswas found in CA patients compared to CL-E-treated patients.
During hemodialysis, C5b-9 levels rose more significantly in (PBMC) during dialysis are still largely unknown. Cyto-
CA patients than in CL-E patients and returned to baseline solic tyrosine and serine kinase activation is a key step
values only in CL-E patients. At the same time, in CA patients in the intracellular signaling pathways leading to cell
an increased iNOS gene expression was observed at T180 to-
proliferation, migration and cytokine secretion [3]. Sev-gether with a striking activation of JNK. By contrast, PBMC
eral leukocyte functions are mediated by changes in pro-from CL-E-treated patients showed undetectable levels of phos-
pho-JNK and a significant reduction in iNOS expression. Inter- tein tyrosine and serine phosphorylation. Indeed, multi-
estingly, incubation of PBMCs with normal human plasma ple cellular proteins, including transcription factors, are
(10%), activated by contact with a cellulosic membrane, in- phosphorylated within seconds after treatment of these
duced a time-dependent increase in JNK phosphorylation that
cells with different agonists [4]. Most of the interleukinswas completely inhibited by blocking complement cascade acti-
exert their actions on monocytes and lymphocytesvation.
through the activation of one or more of the Janus ki-
nases, a family of cytoplasmic tyrosine kinases [5, 6]. On
1 These authors contributed equally to the present study. the other hand, the T cell receptor itself is associated
with a tyrosine kinase, lck, and activates a variety ofKey words: hemodialysis, intracellular signaling, Jun N-terminal ki-
serine kinases, including several enzymes of the mitogen-nase, mononuclear cells, vitamin E, biocompatibility, dialysis mem-
branes. activated protein (MAP) kinase superfamily [7, 8].
The contribution of the complement system in theReceived for publication September 18, 2001
intracellular events associated with PBMC activationand in revised form January 3, 2002
Accepted for publication March 5, 2002 during dialysis remains a debated issue. An increasing
body of evidence suggests that terminal complement 2002 by the International Society of Nephrology
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complexes C5b-7, C5b-8 and C5b-9, at sublytic concen- cellulose acetate (CA) dialyzer for a mean of 4.0 hours
thrice weekly when entering the study. None of themtrations, can produce non-lethal cell-activating signals
[9]. A variety of second messengers, including cyclic had signs of diabetes, lipid metabolism defects, infection,
leukopenia, active immunologic process or malignancyadenosine monophosphate (cAMP), inositol phosphate
intermediates and arachidonate metabolites, are gener- at the time of the study. In addition no medications (anti-
inflammatory drugs, corticosteroids, vitamin C) poten-ated by the terminal complement complexes in several
cell types [10, 11]. In addition, C5b-9 has recently been tially interfering with the parameters under investigation
were administered throughout the study. Underlying dis-shown to activate different cytoplasmic tyrosine kinases
and the ras-raf-MAP kinase signaling cascade [12]. eases leading to end-stage renal failure were chronic
glomerulonephritis (4 patients), interstitial nephritis (2Hemodialysis patients are chronically exposed to oxi-
dative stress, due to an increased production of reactive patients) and cystic disease (2 patients).
oxygen species (ROS) and a reduced level of anti-oxi-
Study designdant compounds [13]. ROS have recently been recog-
nized as signaling molecules [14]. Indeed, oxidants can All hemodialyzed patients, in a randomized manner,
were treated for two subsequent periods of three monthsdirectly activate different cytoplasmic as well as receptor-
associated tyrosine kinases [15–17]. In addition, ROS either with the CA hollow fiber dialyzer (CA 180; mem-
brane surface 1.4 m2; Althin, Milan, Italy) or with theare known to regulate several cell functions through the
activation of some stress-activated protein kinases, such Excebrane E membrane (CL-E 15; membrane surface
1.5 m2). After 36 sequential treatments, the patients wereas p38 mitogen-activated protein kinase (MAPK p38)
and jun-N-terminal kinase (JNK) [18, 19]. In particular, switched from CA to CL-E membranes and vice versa for
another 36 treatments. Hemodialysis efficiency, as indi-JNK has been shown to mediate cellular stress responses
and it is activated by environmental stress factors includ- cated by pre- and post-treatment serum urea and the weight
loss over each dialysis session, remained unchanged duringing ultraviolet light [20], heat shock [21] and pro-inflam-
matory cytokines [22, 23]. Once activated, JNK in turn the study periods. Dialyzers were not reused. Endotoxin
content of the dialysate, as shown by colorimetric Limu-can catalyze the phosphorylation of jun, thus promoting
its interaction with fos to form an active activator pro- lus Amebocyte Lysate assay (Coatest Kabi Vitrum, Swe-
den), was constantly less than 0.05 EU/mL.tein-1 (AP-1) [20]. This transcription factor can then
modulate the gene expression of several cytokines and
White blood cell countgrowth factors [24].
Recently, a new vitamin E-modified cellulosic mem- Using an electronic counter, leukocytes and monocyte
counts were performed in plasma (ethylenediaminetet-brane (CL-E; Excebrane, Terumo, Japan) has been in-
troduced in dialysis. This modified membrane has been raacetic acid; EDTA) samples collected from arterial
side of the patient’s arteriovenous fistula prior to theshown to exert a specific and timely scavenging of oxygen
free radicals, including nitric oxide (NO), thus reducing onset of dialysis and 15 and 180 minutes thereafter.
the hemodialysis-induced oxidative stress [25]. More-
Assay for complement fragments C5b-9over, the modified surface seems to improve the biocom-
patibility profile of this dialyzer [26, 27]. Thus, in the The EDTA anticoagulated samples were drawn be-
fore dialysis (T0) from the arteriovenous fistula, duringpresent study we evaluated the modulation of inducible
nitric oxide synthase (iNOS) gene expression and JNK dialysis (T15 and T180 min) from the venous lines of the
dialyzer and, finally, 4 hours after each dialysis sessionactivation in PBMC during hemodialysis, and the poten-
tial effect of the vitamin E-coated membrane on these (T480). The specimens were collected aseptically, centri-
fuged at 4C and stored at70C until processed. Detec-two molecular events.
tion of C5b-9 was based on a double-sandwich enzyme-
linked immunosorbent assay (ELISA) system using
METHODS
specific antibodies for the terminal complement complex
Patients (Quidel, USA). Mean normal values for C5b-9 were
0.18  0.05 g/mL (mean  SD).Eight stable hemodialyzed patients (4 men, 4 women,
mean age 43.2 years, range 20 to 65 years), having given
Isolation of human PBMC and Western blot analysistheir informed consent, were enrolled in the study; eight
healthy subjects (4 males and 4 females, mean age 41.2 After three months of treatment with CA or CL-E,
blood samples (25 mL) were drawn in sterile heparinizedyears) matched for sex and age represented the control
group. Patients were stabilized on renal replacement vacuum tubes from the patients’ arteriovenous fistulae
just before (T0) and subsequently from the efferent linetherapy for more than six months prior to the study
(mean dialytic age 24.2 months; range 12 to 55 months) of the dialyzer after 180 minutes (T180) of the dialysis
session. PBMC were separated on a Ficoll/Hypaque gra-and were treated with bicarbonate hemodialysis using a
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dient (Pharmacia, Uppsala, Sweden). Cells were washed mmol/L dithiothreitol (DTT)/10 units human placental
RNase inhibitor/6 mmol/L MgCl2/10 mmol/L Tris-HCl,with 0.9% NaCl solution and remaining erythrocytes
pH 7.5/2 mmol/L spermidine/10 mmol/L NaCl) includingdestroyed by hypotonic lysis using 0.2% and 1.6% NaCl
1 g of linearized plasmid and 16 units of either SP6 orsolutions. Isolated PBMC were lysed with RIPA buffer
T7 RNA polymerase. The reaction was allowed to proceed[1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 5
for 60 minutes at 38C. The plasmid DNA was removedmmol/L EDTA, 1 mmol/L sodium orthovanadate, 150
by digestion with 25 mg/mL RNase-free DNase I in ammol/L sodium chloride, 8g/mL leupeptin, 1.5% Noni-
mixture containing 2.5 mg/mL of yeast tRNA and 10det P-40, 20 mmol/L Tris-HCl, pH 7.4] and centrifuged
units of RNase inhibitor for 10 minutes at 37C. Freeat 10,000  g for 30 minutes at 4C. The lysate superna-
ribonucleotides were removed by phenol-chloroform ex-tant was collected, and its protein content determined
traction followed by ethanol precipitation. RNA probeusing the Bio-Rad reagent (Bio-Rad, Munich, Ger-
were then diluted in hybridization buffer, stored at80Cmany). Twenty micrograms of protein from each lysate
and used within four weeks. The specific activity usuallywere mixed with sodium dodecyl sulfate (SDS) sample
obtained was 1.2 to 1.4  109 cpm/g of 35S-labeled RNAbuffer, aliquots were separated by SDS-polyacrylamide
probe.gel electrophoresis (SDS-PAGE; 7.5% acrylamide) and
Prehybridization, hybridization, removal of non-spe-electrophoretically transferred onto a nitrocellulose fil-
cifically bound probe by RNase A digestion, and furtherter. The filter was blocked overnight at room tempera-
washing procedures were performed for both sense andture (RT) with 2% bovine serum albumin (BSA) in phos-
antisense probes as described previously [28]. Autoradi-phate-buffered saline (PBS) containing 0.1% Tween-20
ography was performed by dipping the dehydrated slides(TBS) and incubated with monoclonal anti-phosphoJNK
into Ilford G5 nuclear emulsion (Ilford, Mobberley Chesh-or anti-phospho p38 MAP kinase antibody (Santa Cruz
ire, UK). The exposed slides were developed using KodakBiotechnology, Santa Cruz, CA, USA) at RT for four
D19 developer (Kodak, Hemel Hampstead, UK), counterhours. The membranes were washed twice in TBS and
stained in eosin-hematoxylin and, finally, mounted.incubated for two hours at RT with horseradish-peroxi-
Inducible nitric oxide synthase gene expression (silverdase-conjugated sheep anti-mouse IgG at 1:1500 dilution
grains) was quantified by a computer-based morphomet-in TBS. The membranes were washed three times at RT
ric analysis system (Optilab Pro 2.6.1 Software; Graftek,in TBS and then once with 0.1% SDS in PBS. The ECL
Villanterio, PV, Italy), using a densitometric procedure.enhanced chemiluminescence system (Amersham, Little
Chalfont, UK) was used for detection. The same mem- In vitro study
branes were then stripped and immunoblotted again with Mini-dialyzer modules containing CA, polyarylether-
anti-human JNK polyclonal antibody (Santa Cruz Bio- sulfone (Arylane, Hospal, France), polyacrylonitrile (AN
technology) at RT for four hours. The immune com- 69, Hospal, France) or CL-E membrane (fiber length 18
plexes were detected on the membranes as described cm, number of fibers 340, effective membrane area 300
above. cm2) were used for in vitro dialysis. Mini-modules and
tubings were primed with normal saline before use.In situ hybridization
Twenty milliliters of heparinized whole blood, with-
Inducible nitric oxide synthase (iNOS) gene expres- drawn from healthy subjects, were uniformly passed
sion in cultured PBMC was studied by in situ hybridiza- through each module at a Qb 1 mL/min for 15 minutes
tion. For this purpose, cytospins of freshly isolated in the presence or in the absence of EDTA at the indi-
PBMC were prepared onto polylysine-coated slides, cated concentrations. Plasma samples were collected
dried briefly on a hot plate (80C) and fixed for 20 min- after dialysis and used to stimulate freshly isolated
utes in 4% paraformaldehyde. PBMC. For this purpose the cells were pre-incubated in
A 1000 bp fragment from human iNOS cDNA (a kind serum-free RPMI overnight and then exposed to the
gift of Dr. Pinzani, University of Florence) was sub- plasma (10% vol/vol) obtained after the in vitro dialysis.
cloned into pGEM3Zf. After linearization of the plasmid At the indicated time points the PBMC were lysed in
with the appropriate restriction endonuclease, T7 or SP6 RIPA buffer as previously described and used for West-
RNA-polymerases (Boehringer Mannheim, Mannheim, ern blot studies. In a separate set of experiments, freshly
Germany), respectively, were employed to obtain run isolated PBMC were resuspended in serum free RPMI
off transcripts of either the antisense (complementary to at 106 cells/mL, passed through the modules and lysed
mRNA) or sense (negative control) strands. Transcription in RIPA buffer. Experiments were performed with blood
and labeling of RNA probes was performed as described from three healthy subjects.
[28]. Briefly, 80 Ci of [35S]uridine-5-(-thio)-triphos-
Statisticsphate (specific activity 1250 Ci/mmol; Amersham) were
added to a 10 mL reaction mixture (0.5 mmol/L each All results have been given as mean standard devia-
tion (SD). Significance was assessed using the paired orof adenosine-, cytosine- and guanosine-5-triphosphate/1
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L) and CL-E membrane (T0 686  44, T15 401  203,
T180 540  183 monocytes/L).
Long-term hemodialysis patients treated with CA
membranes showed increased predialysis (T0) plasma
C5b-9 levels as compared to CL-E treated patients and
normal controls (P 	 0.005; Fig. 1). Moreover, a rapid
significant increase of C5b-9 levels occurred at T15 in
both groups as compared to baseline values. Thereafter,
the generation of the terminal complement complex
reached a plateau, which lasted up to 180 minutes after
the beginning of dialysis (Fig. 1). Interestingly, at T480,
plasma C5b-9 concentration rapidly returned to baseline
values in CL-E patients, whereas a slower fall-off was
observed in CA-treated patients. Indeed, at T480, C5b-9
in this group of patients remained significantly (P 	
0.005) higher as compared to patients in hemodialysis
with CL-E filters and controls (Fig. 1B).
Effect of CL-E membrane on PBMC activation
To evaluate the level of activation of circulating mono-
nuclear cells, we investigated PBMC iNOS expression
during dialysis with CA and CL-E membranes [29, 30].
An extremely high iNOS mRNA expression was ob-
served, by in situ hybridization, in PBMC isolated from
CA treated patients, in particular after three hours of
dialysis (230,875  32,152 AU/pixel; Fig. 2A). Interest-
ingly, iNOS expression was dramatically reduced in
PBMC from patients undergoing dialysis with the vita-
min E-coated membrane (50,689 10,253 AU/pixel, P	
0.01 vs. CA treatment; Fig. 2B).
Dialysis-dependent stress kinases modulation
Oxidative stress and cytokines generated during HD
Fig. 1. (A) Leukocyte counts during hemodialysis with a cellulosic may activate JNK [18, 19]. Interestingly, after 180 min-membrane (CA; ) and Excebrane-E (CL-E; ). *P 	 0.05 vs. CA
utes of dialysis patients treated with CA membranesT0; **P 	 0.05 vs. CA T15. (B) C5b-9 generation during hemodialysis
with CA () and CL-E (). Plasma concentrations of C5b-9 were presented a striking increase in the phosphorylation of
measured by ELISA as described in the Methods section. The dotted
both JNK-1 and JNK-2, the two main isoforms of theline represents the mean C5b-9 concentration in the control group
(0.18  0.05 g/mL); *P 	 0.005 vs. CL-E membrane. enzyme (Fig. 3). On the other hand, undetectable levels
of phospho-JNK were observed when the patients were
switched to CL-E (Fig. 3). Either CA or CL-E treatment
did not influence the JNK protein expression (Fig. 3).
unpaired Student t test, as appropriate. Differences were The dialysis-induced changes in protein phosphorylation
considered to be significant when P 	 0.05. were specific for JNK and were not observed for the
other stress-activated kinase, MAPK p38 (Data not
shown).
RESULTS
PBMC activation in vitroLeukocyte counts and C5b-9 generation
during dialysis To investigate the mechanisms underlying JNK activa-
tion during hemodialysis we moved to an in vitro dialysisCirculating leukocyte counts dropped after 15 minutes
system. First, the in vivo observation of a reduced JNKof hemodialysis both in CA- and CL-E–treated patients,
phosphorylation by CL-E was confirmed. Indeed, normalalthough the reduction was statistically significant (P 	
plasma that had been previously dialyzed in vitro with0.005) only in the CA group (Fig. 1A). The number of
monocytes showed a similar pattern for both CA (T0 CA membrane induced a striking phosphorylation only
of JNK-1 in freshly isolated PBMC, whereas CL-E dia-654  122, T15 331  167, T180 631  238 monocytes/
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Fig. 3. Modulation of JNK phosphorylation induced by dialysis with
CA or CL-E membrane. PBMC were isolated and lysed at T0 and
T180. Phosphorylated JNK (top) was studied by western blotting using
a specific monoclonal anti-phosphoJNK antibody as described in the
Methods section. The same membranes were then stripped and immu-
noblotted again with anti-JNK monoclonal antibody (bottom). Treat-
ment with CA, but not with CL-E, induces a striking increase of both
JNK1 and JNK2 phosphorylation at T180. Data are representative of
eight patients.
in serum free RPMI were passed through the dialysis
modules. The direct contact of PBMC with CA mem-
brane caused a striking phosphorylation of both JNK-1
and JNK-2 that was not present in the cells incubated
with CL-E (Fig. 7).
Fig. 2. Inducible nitric oxide synthase (iNOS) gene expression in pe-
ripheral blood mononuclear cells (PBMC) of hemodialysis patients
treated with different membranes. iNOS gene expression was studied DISCUSSION
by in situ hybridization as described in the Methods section. Bright
There is an increasing body of evidence suggestingfield photomicrographs of PBMC isolated after 180 minutes of dialysis
from patients treated with CA (A) or CL-E (B) membranes. CA treat- that lymphomononuclear cell activation and subsequent
ment induces a clear up-regulation of iNOS mRNA, whereas the treat- cytokine expression may play a key role in the pathogen-ment with CL-E reduces it. Photomicrographs are representative of
esis of several dialysis-related pathological conditions,eight patients.
including malnutrition, anemia, accelerated atheroscle-
rosis and immune dysfunction [31]. While the importance
of dialyzer biocompatibility in the prevention of several
lyzed plasma did not change the JNK phosphorylation dialysis complications is now clearer, the cellular and
level, as compared to untreated PBMC (Fig. 4). molecular mechanisms underlying membrane-induced
To evaluate the influence of the complement system immune cell activation are still largely unclear.
activation in this signaling event, C5b-9 generation was The present study demonstrates, to our knowledge for
blocked by adding EDTA (10 mmol/L) during the in the first time, that dialysis with cellulosic membrane can
vitro dialysis with CA membrane. EDTA significantly induce the phosphorylation and the subsequent activa-
reduced C5b-9 levels in the dialyzed plasma (without tion of JNK. This intracellular event is temporarily re-
EDTA 3.3  0.24 g/mL; with EDTA 0.3 0.01 g/mL; lated to a striking activation of circulating mononuclear
P 	 0.001) and caused a marked reduction in the ability cells, as suggested by the increased iNOS gene expres-
of CA-dialyzed plasma to induce JNK phosphorylation sion, and with a significant increase in C5b-9 generation.
(Fig. 5). In addition, plasma dialyzed in vitro with two Interestingly, in vitro inhibition of complement cascade
synthetic membranes, well-known to cause a low C5b-9 priming markedly reduces the JNK phosphorylation.
generation, was unable to induce any significant change Complement activation is a major feature in bioincom-
in JNK phosphorylation (Fig. 6). patibility phenomena. The presence of high C5b-9
Finally, to evaluate the role of cell-membrane interac- plasma levels just prior to dialysis suggests that a chronic
complement activation state exists in CA-treated pa-tion in HD-induced JNK activation, PBMC resuspended
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Fig. 4. (A) In vitro effect of CA and CL-E membranes on JNK phos-
phorylation. Twenty milliliters of heparinized whole blood, drawn from
healthy subjects, were dialyzed in vitro with CA or CL-E, as described
in the Methods section. Plasma samples were collected after dialysis
and used to stimulate freshly isolated PBMC. For this purpose the cells
Fig. 5. (A) Complement-dependent JNK phosphorylation during inwere pre-incubated in serum-free RPMI overnight and then exposed
vitro dialysis. Twenty mL of heparinized whole blood, drawn fromfor 15 minutes to the plasma (10% vol/vol) obtained after the in vitro
healthy subjects, was dialyzed in vitro in the presence or in the absencedialysis. JNK phosphorylation (A) was evaluated. The same membranes
of EDTA (10 mmol/L). Plasma samples were collected after dialysiswere then stripped and immunoblotted again with anti-JNK monoclonal
and used to stimulate freshly isolated PBMC. For this purpose the cellsantibody (lower panel in A). Data are representative of three indepen-
were pre-incubated in serum-free RPMI overnight and then exposeddent experiments. (B) Densitometry analysis was performed on the
for 15 minutes to the plasma (10% vol/vol) obtained after the in vitroblots by a computer-assisted image analysis system. The levels of p-JNK
dialysis. JNK phosphorylation (A) was evaluated as described in thewere normalized to the total content of the enzyme and expressed as
Methods section. The same membranes were then stripped and immu-a ratio (p-JNK/JNK). *P 	 0.001 vs. CA.
noblotted again with anti-JNK monoclonal antibody (A, lower panel).
Data are representative of three independent experiments. (B) Densito-
metric analysis was performed on the blots by a computer-assisted image
analysis system. The levels of p-JNK were normalized to the total
tients in the interdialytic period. This might be explained content of the enzyme and expressed as a ratio (p-JNK/JNK). *P 	
0.001 vs. CA.by the relative inefficacy of these membranes to elimi-
nate middle molecules such as factor D, a serine esterase
with a molecular weight of 23 kD able to trigger the
tration of factor D might be responsible for the enhancedactivation of the alternative pathway [32]. Moreover, a
activation of the alternative pathway in uremic patientsmarked lowering of serum S protein (Vitronectin), a
and account for a continuous generation of C5b-9, notcontrol protein of C5b-9 complex, has been reported in
hemodialyzed patients [33]. Thus, the elevated concen- sufficiently controlled by S protein [34]. Activated com-
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Fig. 6. (A) In vitro effect of different dialytic membranes on JNK
phosphorylation. Twenty milliliters of heparinized whole blood, drawn
from healthy subjects, were dialyzed in vitro with CA, AN 69 and
Arylane, as described in the Methods section. Plasma samples were
collected after dialysis and used to stimulate freshly isolated PBMC.
To this purpose the cells were pre-incubated in serum-free RPMI over-
night and then exposed for 15 minutes to the plasma (10% vol/vol)
obtained after the in vitro dialysis. JNK phosphorylation (A) was evalu-
ated as described. The same membranes were then stripped and immu-
noblotted again with anti-JNK monoclonal antibody (A, lower panel). Fig. 7. (A) Direct membrane effect on JNK phosphorylation. Freshly
Data are representative of three independent experiments. (B) Densito- isolated PBMC obtained from healthy subjects were resuspended in
metric analysis was performed on the blots by a computer-assisted serum-free RPMI at 106/mL dialyzed in vitro as described in the Methods
image analysis system. The levels of p-JNK were normalized to the section, and lysed in RIPA buffer. JNK phosphorylation (A) was evalu-
total content of the enzyme and expressed as a ratio (p-JNK/JNK). ated. The same membranes were then stripped and immunoblotted
*P 	 0.001 vs. basal; #P 	 0.001 vs. CA. again with anti-JNK monoclonal antibody (A, lower panel). Data are
representative of three independent experiments. (B) Densitometric
analysis was performed on the blots by a computer-assisted image
analysis system. The levels of p-JNK were normalized to the total
content of the enzyme and expressed as a ratio (p-JNK/JNK). *P 	plement components and, in particular the terminal com- 0.001 vs. CA.
plement complex, can modulate several cell functions
through the activation of different signaling pathways
[9]. Sublytic doses of C5b-9 have been shown to induce an increased production of reactive oxygen species and
inositol phosphate generation, calcium influx and cyto- a significant up-regulation of interleukin-6 (IL-6) gene
plasmic protein tyrosine phosphorylation [9–12]. Inter- expression [35]. This pro-inflammatory cellular effect of
the complement terminal complex is completely inhib-estingly, Viedt et al recently reported that C5b-9 causes
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ited by the antioxidant N-acetylcysteine, suggesting that circulating immune cells may lead to a significant release
of ROS [35]. It is conceivable, then, that the high localoxidative stress may represent one of the main mediators
of C5b-9 signaling and subsequent modulation of cellular concentration of vitamin E may dramatically reduce the
oxidative load, as reported by Tarng et al [26]. In turn,functions [35].
Oxidative stress during dialysis is particularly deleteri- this can reduce JNK activation and eventually iNOS gene
expression. Indeed, in the 5 flanking sequence of theous, since dialysis patients present a significant reduction
of the anti-oxidant defense, mainly due to the loss of iNOS gene there are two AP-1 binding sites whose rele-
vance in iNOS gene modulation in response to differentvitamins C and E [13]. Circulating immune cells are
extremely sensitive to this stimulus. Indeed, ROS can cytokines has been recently reported [39, 40]. However,
on the basis of our in vitro and in vivo data we cannotactivate several intracellular signaling pathways in lymph-
omononuclear cells. In this scenario, the stress-activated exclude the possibility that complement activation or
membrane-cell interaction might induce iNOS gene ex-kinases represent a primary target [14]. This recently
recognized family of MAP kinases, including JNK and pression in a JNK-independent manner.
In conclusion, our data suggest that JNK phosphoryla-p38 MAPK, seems to play a key role in the signaling
system leading to cell activation in response to a broad tion is strikingly increased in PBMC obtained from CA-
treated patients and may represent a key cellular eventrange of external stimuli [18–22]. The signaling through
JNK causes the activation of different transcription fac- in PBMC activation during dialysis with bioincompatible
membranes. The activation of this signaling enzyme, me-tors, including AP1 and ATF2, which in turn can induce
an increased transcription of cytokines and growth fac- diated by active complement fragments and PBMC-dia-
lyzer interaction, can be significantly reduced by the usetors, a hallmark of bioincompatibility [24]. JNK present
two main isoforms, JNK-1 and JNK-2 transcribed by two of vitamin E-coated membrane. Therefore, the develop-
ment of this “third generation” dialyzer might provideindependent genes, with mostly overlapping functions in
immune cells [36–38]. In our in vivo study we observed a specific and efficient tool to prevent the continuous
immune activation induced by dialysis and its long-termthe phosphorylation of both isoforms. Interestingly, the
in vitro stimulation of PBMC with plasma dialyzed using clinical consequences in hemodialyzed patients.
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